Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM
International Journal of Molecular Sciences · 01.09.2023 · 24 (17) · 13562
DOI: 10.3390/ijms241713562 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.09.2023. Verfasst von Francisco Andújar-Vera und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatic Unit, Biosanitary Research Institute ibs.GRANADA, 18012 Granada, Spain. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Institute of Health Carlos III, Servicio Andaluz de Salud.
Abstract (Originalsprache)
Hepatotoxicity, a common adverse drug effect, has been extensively studied in adult patients. However, it is equally important to investigate this condition in pediatric patients to develop personalized treatment strategies for children. This study aimed to identify plasma biomarkers that characterize hepatotoxicity in pediatric patients through an observational case–control study. Metabolomic analysis was conducted on 55 pediatric patients with xenobiotic liver toxicity and 88 healthy controls. The results revealed clear differences between the two groups. Several metabolites, including hydroxydecanoylcarnitine, octanoylcarnitine, lysophosphatidylcholine, glycocholic acid, and taurocholic acid, were identified as potential biomarkers (area under the curve: 0.817; 95% confidence interval: 0.696–0.913). Pathway analysis indicated involvement of primary bile acid biosynthesis and the metabolism of taurine and hypotaurine (p < 0.05). The findings from untargeted metabolomic analysis demonstrated an increase in bile acids in children with hepatotoxicity. The accumulation of cytotoxic bile acids should be further investigated to elucidate the role of these metabolites in drug-induced liver injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioinformatic Unit, Biosanitary Research Institute ibs.GRANADA, 18012 Granada, Spain.
- Department of Pediatrics, University of Granada, 18016 Granada, Spain.
- Department of Pediatrics, "Virgen de las Nieves" University Hospital, 18014 Granada, Spain.
- Research Support Unit, Biosanitary Research Institute ibs.GRANADA, 18012 Granada, Spain.
- Research Unit, GenActive Clinic & Research, 18193 Granada, Spain.
- Biosanitary Research Institute ibs.GRANADA, 18012 Granada, Spain.
ORCID-Profile: Francisco Andújar-Vera, Esther Ocete-Hita
Förderung
- Instituto de Salud Carlos III
- Institute of Health Carlos III
- Servicio Andaluz de Salud
Zitieren
APA
Andújar-Vera, F., Alés-Palmer, M. L., Muñoz-de-Rueda, P., Iglesias-Baena, I., & Ocete-Hita, E. (2023). Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. International Journal of Molecular Sciences, 24(17), 13562. https://doi.org/10.3390/ijms241713562
Vancouver
Andújar-Vera F, Alés-Palmer ML, Muñoz-de-Rueda P, Iglesias-Baena I, Ocete-Hita E. Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. International Journal of Molecular Sciences. 2023;24(17):13562. doi:10.3390/ijms241713562
BibTeX
@article{AndjarVera2023,
author = {Andújar-Vera, Francisco and Alés-Palmer, María Luisa and Muñoz-de-Rueda, Paloma and Iglesias-Baena, Iván and Ocete-Hita, Esther},
title = {Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {17},
pages = {13562},
doi = {10.3390/ijms241713562}
}
EUVIMED